Behavioral Intervention for Children With Attention Deficit Hyperactivity Disorder(ADHD)

December 30, 2014 updated by: Min Chen

Study on the Psychological Behavior Intervention Technology of Attention Deficit Hyperactivity Disorder

ADHD children have executive function (EF) impairments,so we randomize the children to the training or a waitlist to improve EF ,adding contingent reinforcement to ascertain whether EF deficits are amenable to the training in children with ADHD.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
      • Beijing, China, 100191
        • Recruiting
        • Peking University Sixth Hospital/Institute of Mental Health
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 12 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • clinical diagnosis of child ADHD
  • full-scale intelligence quotient (FSIQ) ≥70
  • stable on medication for ADHD children at least 3 months

Exclusion Criteria:

  • individuals with major neurological disorders
  • a diagnosis of schizophrenia, epilepsy, mental retardation or other brain disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Executive function training
Children diagnosis of ADHD are randomized to the experimental condition(Executive Function training) or waiting group experimental:participants will receive 12 sessions of executive function training weekly no intervention :waiting participants will not be treated with executive function therapy and keep waiting for 12 weeks for comparison
Behavioral: A randomized controlled study of Executive Function training for children with ADHD
Children diagnosis of ADHD are randomized to the experimental condition(Executive Function therapy) or waiting group experimental:participants will receive 12 sessions of executive function therapy weekly no intervention :waiting participants will not be treated with executive function therapy and keep waiting for 12 weeks for comparison

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
change in ADHD-rating scale
Time Frame: baseline,after the training (12week)
baseline,after the training (12week)

Secondary Outcome Measures

Outcome Measure
Time Frame
change in behavior rating scale of executive function
Time Frame: baseline,after the training (12week)
baseline,after the training (12week)
cambridge Neuropsychological Test Automatic Battery
Time Frame: baseline,after the training (12week)
baseline,after the training (12week)
Conners
Time Frame: baseline,after the training (12week)
baseline,after the training (12week)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Min Chen

Investigators

  • Study Director: li yang, PHD MD, Peking University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Anticipated)

December 1, 2015

Study Completion (Anticipated)

December 1, 2016

Study Registration Dates

First Submitted

December 12, 2014

First Submitted That Met QC Criteria

December 24, 2014

First Posted (Estimate)

December 30, 2014

Study Record Updates

Last Update Posted (Estimate)

December 31, 2014

Last Update Submitted That Met QC Criteria

December 30, 2014

Last Verified

December 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2011-4024-04

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe